Thursday, September 29, 2022 2:57:59 PM
LifeSci Partners HealthTech Symposium – September 20-21, 2022
Title: Beyond Air (XAIR) Fireside Chat
Date & Time: Wednesday, September 21, 2022, at 12:00 – 12:25pm ET
Moderator: Corey Davis, Ph.D., LifeSci Advisors, LLC
Participant: Steve Lisi, Chairman & CEO, Beyond Air
Location: Virtual
Webcast Link: Link
Ladenburg Thalmann Healthcare Conference – September 29, 2022
Title: Beyond Air (XAIR) Company Presentation
Date & Time: Thursday, September 29, 2022, at 1:30pm – 1:55pm ET
Presenter: Steve Lisi, Chairman & CEO, Beyond Air
Location: Sofitel New York City
Webcast Link: Link
Roth Inaugural Healthcare Opportunities Conference – October 6, 2022
Title: Beyond Air (XAIR) Company Presentation
Date & Time: Thursday, October 6, 2022, (Time - TBD)
Presenter: Steve Lisi, Chairman & CEO, Beyond Air
Location: The Yale Club, New York City
Webcast Link: TBD
https://stockhouse.com/news/press-releases/2022/09/16/beyond-air-xae-to-participate-in-three-upcoming-investor-conferences
Recent XAIR News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/01/2024 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:15:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:06:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 10:16:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/08/2024 01:37:17 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/26/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:15:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/20/2023 10:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:10:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:16:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:00:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/22/2023 04:15:25 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/11/2023 08:44:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 09:15:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM